v3.26.1
SHARE-BASED COMPENSATION (Details Narrative) - USD ($)
12 Months Ended
Mar. 18, 2026
Jun. 30, 2026
Jun. 30, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Recognized share based compensation   $ 97,633 $ 190,045
Unrecognized share-based compensation expenses related to unvested awards   $ 323,447  
Weighted-average period   11 months 8 days  
Restricted Stock [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Vesting restricted stock awards shares    
Restricted Stock [Member] | 12-month Anniversary [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Vesting restricted stock awards shares 20,000    
Restricted Stock [Member] | 48-month Anniversary [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Vesting restricted stock awards shares 10,500    
Restricted Stock [Member] | 48-month Anniversary [Member] | Chief Executive Officer [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Vesting restricted stock awards shares 9,150    
Restricted Stock [Member] | 48-month Anniversary [Member] | Chief Financial Officer [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Vesting restricted stock awards shares 9,150    
Performance Based Restricted Stock Awards [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award These Performance-Based RSAs vest in tranches and upon the satisfaction of the following performance conditions: (1) 30% of the shares vest on the later of (i) the date certified by the Committee as the date on which a specified clinical trial milestone has been achieved, and (ii) the one-year anniversary of the grant date, subject to continued service through the vesting date, (2) 40% of the shares vest on the later of (i) the date of completion of a specified regulatory submission to the FDA, and (ii) the one-year anniversary of the Grant Date, subject to continued service through the vesting date, and (3) 30% of the shares vest on the later of (i) the date certified by the Board of Director’s Compensation Committee as the date on which a specified commercial supply and sales milestone has been achieved, and (ii) the one-year anniversary of the Grant Date, subject to continued service through the vesting date.    
Performance Based Restricted Stock Awards [Member] | Chief Executive Officer [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures 21,350    
Performance Based Restricted Stock Awards [Member] | Chief Financial Officer [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures 21,350    
Performance Based Restricted Stock Awards [Member] | Employees [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Vesting restricted stock awards shares 24,500